Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinhan He

Showing results (71-80 of 122) with videos related to

Pageof 13
Sort By:
Gastroenterology|February 5, 2008
Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosisJie Zhou, Maria Febbraio, Taira Wada, et al.
Diabetes, Obesity & Metabolism|February 25, 2025
Tirzepatide reduces body weight by increasing fat utilization via the central nervous system-adipose tissue axis in male miceAilin Zhang, Qinhui Liu, Yimin Xiong, et al.
Molecular Pharmaceutics|January 30, 2026
Chondroitin Sulfate-Based ROS-Responsive Nanoparticles Targeting Activated Myofibroblasts via CD44 Receptors for the Renal Fibrosis TherapyWei Zhao, Jie Zhou, Yan Xia, et al.
Journal of Pharmaceutical Analysis|January 15, 2024
Glutaredoxin-1 alleviates acetaminophen-induced liver injury by decreasing its toxic metabolitesYing Xu, Yan Xia, Qinhui Liu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 21, 2019
An integrin-based nanoparticle that targets activated hepatic stellate cells and alleviates liver fibrosisYanping Li, Shiyun Pu, Qinhui Liu, et al.
Biomaterials|July 7, 2023
Dually fibronectin/CD44-mediated nanoparticles targeted disrupt the Golgi apparatus and inhibit the hedgehog signaling in activated hepatic stellate cells to alleviate liver fibrosisYanping Li, Ting Zhang, Jinhang Zhang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 7, 2025
A two-pronged nanomedicine counteracts obesity by remodeling adipose nicheLingling Wang, Jiahao Chen, Jingwei Li, et al.
Metabolism: Clinical and Experimental|June 5, 2023
Glutaredoxin 1 regulates cholesterol metabolism and gallstone formation by influencing protein S-glutathionylationYan Xia, Ying Xu, Qinhui Liu, et al.
Molecular and Cellular Biology|November 27, 2013
Cholesterol sulfate and cholesterol sulfotransferase inhibit gluconeogenesis by targeting hepatocyte nuclear factor 4αXiongjie Shi, Qiuqiong Cheng, Leyuan Xu, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 19, 2024
Homomultivalent Polymeric Nanotraps Disturb Lipid Metabolism Homeostasis and Tune Pyroptosis in CancerJie Zhou, Jiecheng Ji, Xue Li, et al.
Pageof 13

Showing results (71-80 of 122) with videos related to

Sort By:
Pageof 13
Gastroenterology|February 5, 2008
Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosisJie Zhou, Maria Febbraio, Taira Wada, et al.
Diabetes, Obesity & Metabolism|February 25, 2025
Tirzepatide reduces body weight by increasing fat utilization via the central nervous system-adipose tissue axis in male miceAilin Zhang, Qinhui Liu, Yimin Xiong, et al.
Molecular Pharmaceutics|January 30, 2026
Chondroitin Sulfate-Based ROS-Responsive Nanoparticles Targeting Activated Myofibroblasts via CD44 Receptors for the Renal Fibrosis TherapyWei Zhao, Jie Zhou, Yan Xia, et al.
Journal of Pharmaceutical Analysis|January 15, 2024
Glutaredoxin-1 alleviates acetaminophen-induced liver injury by decreasing its toxic metabolitesYing Xu, Yan Xia, Qinhui Liu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 21, 2019
An integrin-based nanoparticle that targets activated hepatic stellate cells and alleviates liver fibrosisYanping Li, Shiyun Pu, Qinhui Liu, et al.
Biomaterials|July 7, 2023
Dually fibronectin/CD44-mediated nanoparticles targeted disrupt the Golgi apparatus and inhibit the hedgehog signaling in activated hepatic stellate cells to alleviate liver fibrosisYanping Li, Ting Zhang, Jinhang Zhang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 7, 2025
A two-pronged nanomedicine counteracts obesity by remodeling adipose nicheLingling Wang, Jiahao Chen, Jingwei Li, et al.
Metabolism: Clinical and Experimental|June 5, 2023
Glutaredoxin 1 regulates cholesterol metabolism and gallstone formation by influencing protein S-glutathionylationYan Xia, Ying Xu, Qinhui Liu, et al.
Molecular and Cellular Biology|November 27, 2013
Cholesterol sulfate and cholesterol sulfotransferase inhibit gluconeogenesis by targeting hepatocyte nuclear factor 4αXiongjie Shi, Qiuqiong Cheng, Leyuan Xu, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 19, 2024
Homomultivalent Polymeric Nanotraps Disturb Lipid Metabolism Homeostasis and Tune Pyroptosis in CancerJie Zhou, Jiecheng Ji, Xue Li, et al.
Pageof 13